Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Trans-platinum complexes as anticancer drugs: recent developments and future prospects.

S Radulovic1, Z Tesic, S Manic

  • 1Dept. Drug Development, Institute for Oncology and Radiology of Serbia, Pasterova 14, Belgrade, 11000, Yugoslavia. sinisar@ncrc.ac.yu

Current Medicinal Chemistry
|August 13, 2002
PubMed
Summary

Trans-platinum compounds show promise as novel cancer drugs, exhibiting activity against cisplatin-resistant tumors and distinct cellular mechanisms. These platinum-based agents offer a new avenue for chemotherapy development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Latest Developments in the Management of Nut Allergies.

Current treatment options in allergy·2021
Same author

Longitudinal analysis of the effect of water hardness on atopic eczema: evidence for gene-environment interaction.

The British journal of dermatology·2019
Same author

Is there a correlation between molecular markers and response to neoadjuvant chemoradiotherapy in locally advanced squamous cell esophageal cancer?

Journal of B.U.ON. : official journal of the Balkan Union of Oncology·2013
Same author

TP53 gene status and human papilloma virus infection in response to platinum plus taxane-based chemotherapy of epithelial ovarian carcinomas.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology·2012
Same author

Expression of ERCC1 protein in biopsy specimen predicts survival in advanced ovarian cancer patients treated with platinum-based chemotherapy.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology·2012
Same author

Systematic reviews of sublingual immunotherapy (SLIT).

Allergy·2011

Area of Science:

  • Medicinal Chemistry
  • Oncology
  • Pharmacology

Background:

  • Cisplatin is a potent chemotherapy drug for various solid tumors.
  • Structure-activity studies established the necessity of cis orientation for platinum complex activity.
  • Historically, trans-platinum compounds were considered inactive.

Purpose of the Study:

  • To investigate the antitumor properties of trans-platinum compounds.
  • To explore the differential pharmacology of trans-platinum complexes compared to cisplatin.
  • To assess the potential of trans-platinum compounds as a new class of anticancer drugs.

Main Methods:

  • Review of structure-activity relationships of platinum complexes.
  • Analysis of in vitro and in vivo studies on trans-platinum compounds.

Related Experiment Videos

  • Comparison of cellular and biochemical pharmacology between cis- and trans-platinum agents.

    • Main Results:

    • Trans-platinum compounds demonstrate in vitro and in vivo antitumor activity.
    • Some trans-platinum complexes are effective against cisplatin-resistant cancer cells.
    • Distinct cellular mechanisms, including monofunctional adducts and interstrand cross-links, are associated with trans-platinum cytotoxicity.

    Conclusions:

    • Trans-platinum compounds exhibit unique pharmacological profiles compared to cisplatin.
    • These agents display efficacy against resistant tumor cell lines.
    • Trans-platinum compounds represent a promising new class of platinum-based anticancer drugs.